TWST Twist Bioscience Corp: Market Capitalization to Book Value Ratio

The valuation of Twist Bioscience (TWST) reflected in this chart is based on its leadership in creating synthetic DNA strands via silicon microchips, which reduces production costs. The current metric stands at 20.38. The stability of biomaterial supplies is supported by a network of automated plants that enhance profitability. In response to a surge in orders, Twist Bioscience (TWST) is expanding its facilities and implementing new robotic synthesizers.

This ratio reflects the market value premium over net equity, allowing for the determination of the degree to which assets are overvalued relative to their book value. By analyzing the price-to-book ratio, an investor assesses the risk of buying at the peak, which is particularly relevant for Twist Bioscience (TWST), which optimizes costs through production outsourcing and the use of cloud platforms for genetic data processing.